Patent Portfolio
A 20-year
patent-backed position.
The portfolio covers stable, solid-form cannabinoids for animal health applications.
Manoira holds its animal health license through its partnership with Sarborg: the Company sold these assets to Sarborg for $65m while retaining an exclusive license to them solely in animal and veterinary health, which is the opportunity Manoira is now pursuing.
CBDA
Stable, solid-form CBDA, FDA-recognised as a novel entity.
CBDA Choline
Co-crystal extension for cognitive and metabolic indications.
THCA
Non-psychoactive precursor, formulated for stability.
CBG
Emerging cannabinoid in pharmaceutical-grade form.
In Development
Prototype products coming soon.
First prototype formulations across the dog, cat and equine ranges are in late-stage development and will be unveiled in the months ahead.